Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study Comparing Neoadjuvant Versus Adjuvant Stereotactic Radiotherapy of Brain Metastases
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche
Summary
The purpose of this study is to evaluate the local control rate on the target lesion at 6, 12, and 24 months after treatment with neoadjuvant stereotactic radiotherapy (SRS NEO group) compared to standard care, adjuvant stereotactic radiotherapy (POST OP SRS group).
Official title: Prospective, Randomized, Multicenter Study Comparing the Efficacy and Tolerance of Neoadjuvant Versus Adjuvant Stereotactic Radiotherapy in the Management of Brain Metastases
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
68
Start Date
2026-04
Completion Date
2030-06-30
Last Updated
2026-03-04
Healthy Volunteers
No
Conditions
Interventions
stereotactic radiotherapy
Stereotactic radiotherapy is part of the standard treatment for brain metastases.
Excision surgery
Brain metastasis removal surgery
Locations (1)
Hôpital Privé Clairval
Marseille, France